Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Trading Update

28 Nov 2023 07:00

RNS Number : 8207U
Crimson Tide PLC
28 November 2023
 

28 November

Crimson Tide plc

("Crimson Tide" or "the Company")

Trading Update

 

Crimson Tide Plc (TIDE) ("Crimson Tide" or "The Company"), the provider of the mpro5 solution, is pleased to provide the following trading update.

In our interim results for the period to 30 June 2023, we highlighted our ongoing focus on profitability and customer success. Since then, we have seen continued interest in our services, driven by clients' impetus towards more efficient environments using mpro5 to verify, audit and improve their processes. At the same time, we have focussed on our own operational efficiency, which, together with continued robust gross margins, means the Board now expects to deliver improved EBITDA from operating efficiencies in the current year, which we now expect to:

· partially reinvest in further growth marketing activities and partner acquisition in the UK and United States; and

 

· drive an EBITDA performance in FY23 of no less than £0.4m* (FY22: LBITDA -£0.4m), significantly ahead of the Board's prior expectation and a reduced Loss Before Tax of approximately £-0.7m (FY22: -£1.7m). The Loss After Tax is expected to be reduced and in the region of £-0.3m (FY22 -£-1.2m). *FY23 turnover is expected to be in line with the Board's current expectations.

The Group is continuing to deliver its objective to build a high growth long-term SaaS business with strong recurring revenues. The sectors in which we operate have been focused on Facilities Management, Retail and Food Service, allowing us to deliver at scale. Our goal is to continue to standardise mpro5 for a wide range of businesses, enabling us to scale through partner acquisition and direct sales to both SMEs and the larger enterprise-level offering. Top-line growth is now open to us across all of these sectors, both in the UK and internationally.

By partially reinvesting the gains achieved, we believe that we are strongly placed and on track to ensure we achieve sustained growth for the business going forward. The Directors remain confident in future performance and believe that our ability to scale the business has never been greater. This is underpinned by a robust balance sheet, strong pipeline of new business and increasing visibility. The Group's current cash position stands at £2.8m, with an R&D tax refund of an anticipated minimum of £0.3m due imminently.

Our foremost goal is to continue to demonstrate robust growth in annually recurring revenues. These positive outcomes demonstrate that we can scale the business very efficiently as we grow our top-line revenues.

Full-year results are expected to be published in early April. The numbers in this update remain subject to audit.

* For the purpose of this announcement, the Group believes market expectations for FY23 to be revenue of £6.2m, and adjusted EBITDA of £0.2m. Adjusted EBITDA is calculated as profit before tax, interest, depreciation, amortisation, share-based payment charges and foreign exchange.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Enquiries:

Crimson Tide plc +44 1892 542444

Barrie Whipp / Jacqueline Daniell

 

Cavendish Capital Markets Ltd (Nominated Adviser and Broker) +44 20 7220 0500

Julian Blunt / Dan Hodkinson - Corporate Finance

Andrew Burdis - Corporate Broking

 

Alma PR (Financial PR) +44 7780 901979

Josh Royston

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRBRTMTITBPJ
Date   Source Headline
30th Jun 202011:53 amRNSResult of AGM and Trading Update
15th Jun 202010:42 amRNSSignificant Contract Win
9th Jun 20204:06 pmRNSAnnual Report and Notice of AGM
7th May 20207:11 amRNSPreliminary Results
4th May 20204:05 pmRNSDIRECTOR RESIGNATION
1st Apr 20203:30 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSStatement regarding Coronavirus
13th Mar 20207:00 amRNSChange of Adviser
25th Feb 20208:19 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSSignificant contract wins in the rail sector
28th Jan 202010:43 amRNSHolding(s) in Company
3rd Jan 20209:17 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSSignificant long-term contract and trading update
1st Oct 20197:00 amRNSSignificant long-term contract win
27th Sep 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSDirector and Company Secretary Appointment
28th Jun 20193:02 pmRNSResult of AGM
27th Jun 20197:00 amRNSContract Wins and New Partnerships
7th Jun 20197:00 amRNSFinal Results and Notice of AGM
17th May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSPreliminary Announcement of Results to 31/12/18
16th Apr 20199:20 amRNSHolding(s) in Company
1st Mar 20192:56 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSContract Wins in the rail sector
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.